Literature DB >> 31707522

Frameless stereotaxy: It is all about precision.

Mostafa M E Atteya1,2.   

Abstract

BACKGROUND: Modern neurosurgery is nowadays based on technological advances. Intra-operative image guidance systems are frequently utilized in the everyday neurosurgical practice. Frameless stereotactic procedures (FSPs) require a great deal of technical abilities and precautions. Frameless stereotaxy mandates a high degree of problem-solving attitude and on-the-spot neurosurgeon's creativity.
OBJECTIVE: In these technical notes, the author aims at presenting his experience in frameless stereotaxy for more than 10 years in the form of easily digestible tricks and pitfalls during every step of FSPs.
METHODS: The author retrospectively distilled the tricks and pitfalls of the FSPs performed by him during the past 10 years according to their chronological status in a how-I-do-it fashion.
RESULTS: Chronologically speaking, phases relating to any FSP were divided into five phases: (1) preoperative image acquisition, (2) pre-operative planning, (3) machine setup, positioning, and registration; (4) operative techniques; and (5) post-operative precautions. Faults in any of these phases can result in failure of the procedure or in faulty surgery with subsequent complications. Each stage is addressed in a how I do it fashion, questions and answers, bulleted or numbered tricks and pitfalls, and, in some instances, what-to-do-if scenarios were given.
CONCLUSION: Frameless stereotaxy is a well-established neurosurgical practice. Many neurosurgeons are only aware with the bare minimum of the technical aspects of frameless stereotaxy and, subsequently, they practice the bare minimum of its applications. FSPs entail a great deal of technical tricks and pitfalls. Awareness of these techniques should be the target of every neurosurgeon.

Entities:  

Keywords:  Frameless stereotaxy; Functional neurosurgery; Neuronavigation; Stereotactic; Stereotaxy

Mesh:

Year:  2019        PMID: 31707522     DOI: 10.1007/s00381-019-04390-y

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  7 in total

1.  Cerebral biopsy: comparison between frame-based stereotaxy and neuronavigation in an oncology center.

Authors:  Carlos Augusto Ferreira Lobão; Janio Nogueira; Antonio Aversa Dutra do Souto; José Antonio de Oliveira
Journal:  Arq Neuropsiquiatr       Date:  2009-09       Impact factor: 1.420

2.  Complications Following Stereotactic Needle Biopsy of Intracranial Tumors.

Authors:  Hani Malone; Jingyan Yang; Dawn L Hershman; Jason D Wright; Jeffrey N Bruce; Alfred I Neugut
Journal:  World Neurosurg       Date:  2015-05-22       Impact factor: 2.104

3.  Frameless stereotactic cerebral biopsy: our experience in 296 cases.

Authors:  Alessandro Frati; Angelo Pichierri; Stefano Bastianello; Antonino Raco; Antonio Santoro; Vincenzo Esposito; Felice Giangaspero; Maurizio Salvati
Journal:  Stereotact Funct Neurosurg       Date:  2011-07-21       Impact factor: 1.875

4.  The role of frameless stereotactic biopsy in contemporary neuro-oncology: molecular specifications and diagnostic yield in biopsied glioma patients.

Authors:  Marius Marc-Daniel Mader; Roman Rotermund; Tobias Martens; Manfred Westphal; Jakob Matschke; Tammam Abboud
Journal:  J Neurooncol       Date:  2018-11-02       Impact factor: 4.130

5.  Accuracy of VarioGuide Frameless Stereotactic System Against Frame-Based Stereotaxy: Prospective, Randomized, Single-Center Study.

Authors:  Ondrej Bradac; Anna Steklacova; Katerina Nebrenska; Jiri Vrana; Patricia de Lacy; Vladimir Benes
Journal:  World Neurosurg       Date:  2017-04-25       Impact factor: 2.104

6.  Towards improving the safety and diagnostic yield of stereotactic biopsy in a single centre.

Authors:  Ruben Dammers; Joost W Schouten; Iain K Haitsma; Arnaud J P E Vincent; Johan M Kros; Clemens M F Dirven
Journal:  Acta Neurochir (Wien)       Date:  2010-08-01       Impact factor: 2.216

7.  Contemporary frameless intracranial biopsy techniques: Might variation in safety and efficacy be expected?

Authors:  Iris S C Verploegh; Victor Volovici; Iain K Haitsma; Joost W Schouten; Clemens M Dirven; Johan M Kros; Ruben Dammers
Journal:  Acta Neurochir (Wien)       Date:  2015-08-29       Impact factor: 2.216

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.